Dalian-based biochemical company; specific product line not established from available knowledge.
Dalian-based biochemical company; specific product line not established from available knowledge.
Moat: none
Headquarters: Dalian, China · Employees: 1,053
Size Dalian Bio-Chem (603360.SS) is a China Materials company (Chemicals: Major Diversified) with a market value of $1.05B, the 2202nd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥10.11 on 6 Nov 2026.
Performance Over six months the shares fell 55.4%, against -30.1% for the median peer and -16.4% for the China market (cap-weighted) — 2nd lowest of 21 in its peer set.
Growth Revenue grew 0.4% over the last twelve months (peer median +2.9%); the operating margin is 16.2% (peer median 12.3%).
Valuation It trades at 23.5× forward earnings against a peer median of 19.2× (3rd most expensive of 14).
Price implies For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -9 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 2.4 points above its cost of capital (5.7% WACC).
Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.48B | CN¥1.72B | CN¥1.26B | CN¥1.05B | CN¥1.24B |
| Revenue growth | — | +36% | +20% | -15% | — |
| Gross profit | CN¥611M | CN¥598M | CN¥542M | CN¥529M | CN¥638M |
| EBITDA | n/a | CN¥473M | CN¥429M | CN¥427M | CN¥517M |
| Net income | CN¥146M | CN¥210M | CN¥392M | CN¥328M | CN¥403M |
| Free cash flow | CN¥167M | CN¥510M | CN¥89.0M | CN¥323M | CN¥347M |
| Capital expenditure | CN¥118M | CN¥36.7M | CN¥74.9M | CN¥67.4M | CN¥134M |
| Total debt | CN¥1.33B | CN¥1.38B | CN¥608M | CN¥180M | CN¥129M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 603360.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -17.1% | -12.1% | 8th lowest of 21 |
| 6-month return | -55.4% | -30.1% | 2nd lowest of 21 |
| Distance from 52-week high | -74.1% | -45.0% | 2nd lowest of 21 |
| Revenue growth (TTM) | +0.4% | +2.9% | 10th lowest of 21 |
| Operating margin | 16.2% | 12.3% | 9th highest of 21 |
| Forward P/E | 23.5× | 19.2× | 3rd most expensive of 14 |
| Growth the price implies (Req g, 7 yrs) | 9.5% | 8.8% | 7th most demanding of 14 |
| Growth delivered (Del g) | +18.4% | +6.3% | 4th highest of 14 |
| Hurdle (Req g minus delivered) | -8.8 pp | -1.5 pp | 4th least demanding of 14 |
| ROIC minus cost of capital | +2.4 pp | -2.1 pp | 6th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Dalian Bio-Chem 603360.SS | China | $1.05B | -55% | 0% | 16% | 23.5× | 9.5% | +18.4% |
| Victrex VCT.L | United Kingdom | $1.04B | +54% | -1% | 14% | 21.7× | 15.7% | +1.9% |
| Caregen 214370.KS | South Korea | $1.01B | -73% | -8% | 24% | 22.6× | 35.2% | +3.8% |
| Jiangsu Zhengdan Chemical Industry 300641.SZ | China | $981M | -28% | -30% | 17% | n/a | 8.8% | +11.6% |
| Jubilant Ingrevia JUBLINGREA.NS | India | $966M | -24% | +15% | 10% | 21.1× | 27.3% | +44.9% |
| Zhejiang Huangma Technology 603181.SS | China | $935M | -30% | +7% | 17% | 14.5× | n/a | n/a |
| Nippon Soda 4041.T | Japan | $1.19B | -5% | -1% | 10% | 11.1× | 3.5% | +1.8% |
| Hubei Jianghan New Materials 603281.SS | China | $1.20B | -30% | +8% | 17% | 20.5× | 4.8% | +6.3% |
| CNSIG Inner Mongolia Chemical Industry 600328.SS | China | $1.21B | -32% | -20% | -7% | n/a | n/a | n/a |
| Xinxiang Richful Lube Additive 300910.SZ | China | $1.26B | -38% | +12% | 16% | 11.6× | 0.6% | +32.5% |
| Jinan Acetate Chemical 4763.TW | Taiwan | $1.26B | -3% | -36% | 46% | 7.3× | -17.4% | +41.2% |
| Guangzhou Sanfu Newmaterials Technology 688359.SS | China | $870M | -41% | +8% | -7% | n/a | n/a | n/a |
| Lanxess LXS.DE | Germany | $1.27B | -30% | -10% | -1% | n/a | 17.9% | -1.5% |
| Suzhou Highfine Biotech 301393.SZ | China | $865M | -8% | +36% | 17% | 32.3× | n/a | n/a |
| Raghav Productivity Enhancers RPEL.NS | India | $864M | +133% | +38% | 28% | n/a | n/a | n/a |
| Hanchem 014680.KS | South Korea | $1.30B | -40% | +15% | 17% | 11.1× | 4.7% | +7.4% |
| Polyrocks Chemical 688669.SS | China | $831M | +40% | -8% | -6% | n/a | 35.9% | +15.2% |
| Sanyo Chemical Industries 4471.T | Japan | $823M | +24% | 0% | 10% | 10.5× | -5.1% | -2.5% |
| Jiangxi Hungpai New Material 605366.SS | China | $821M | -47% | +2% | -11% | 236.0× | n/a | n/a |
| China Resources Chemical Innovative Materials 301090.SZ | China | $1.35B | -33% | +4% | 1% | 19.2× | 21.4% | +1.1% |
| Isuspecialtychemical 457190.KS | South Korea | $1.36B | -49% | +14% | 3% | n/a | n/a | n/a |